Similarly, natural products that improve inflammatory disease and colitis-associated CRC are shown to inhibit inflammatory responses, oxidative stress, and mucosal injury by enhancing gut microbial composition and signaling via the Nrf2/HO-1 pathway. This evidence concerns the gene NFE2L2 and colorectal carcinoma.